Hospital
Portercare Adventist Health System
Portercare Adventist Health System was paid $384K by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
33Billing provider infoPORTERCARE ADVENTIST HEALTH SYSTEM
CASTLE ROCK, CO 80109
CASTLE ROCK, CO 80109
33aNPI1912249590assigned 03/21/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$384K
24GClaims13,912
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#35 of 51
Median peer was paid$1.24M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 963 | $22K | |
| 2019 | 878 | $7K | |
| 2020 | 760 | $26K | |
| 2021 | 2,365 | $45K | |
| 2022 | 2,737 | $85K | |
| 2023 | 4,841 | $167K | |
| 2024incomplete | 1,368 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 818 | 738 | $131K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 359 | 332 | $61K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 510 | 484 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | 10% | 127 | 106 | $39K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 9.2% | 84 | 79 | $35K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 73 | 66 | $28K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.8% | 526 | 162 | $15K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 1.8% | 804 | 720 | $7K |
| 0002A | 1.4% | 72 | 62 | $5K | |
| 0001A | 1.1% | 88 | 80 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 220 | 61 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 681 | 637 | $3K |
22 more codes
| 73130 | <1% | 12 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 232 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $937.36 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,163 | $404.52 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,034 | $404.52 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,389 | $396.43 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 650 | $388.02 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14 | $349.86 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 125 | $103.16 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 319 | $27.94 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 646 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 286 | $0.00 |
| 99152 | 0% | 40 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 653 | $0.00 |
| 0753T | 0% | 272 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 918 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 90 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 70 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 444 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 139 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 29 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAITKEN, MICHAEL (CFO)